Q?rius (pronounced “Curious”) is a new hub of scientific activity and education based at the Smithsonian’s National Museum of Natural History in Washington D.C. The product of a partnership between Olympus and the Smithsonian, the 10,000-square-foot experiential learning center will be equipped with dozens of microscopes and imaging systems that will enable museum visitors more than 6,000 bones, minerals, and fossils.
Even as Silicon Valley speaks out against the U.S...
Funded by prominent Silicon Valley investors and...
The most tweeted peer-reviewed articles published...
From green electricity tariffs to car sharing schemes, many sustainable products and services are being brought to market by start-ups. However, there has been relatively little research into how and why individuals take this step and whether their start-ups become a success. Fourteen European institutes coordinated by the Technical Univ. of Munich will be investigating this trend to see what potential it holds for a sustainable economy.
The solar panel installer SolarCity is beginning to address one of solar power's big drawbacks: The sun doesn't always shine. The solution: big battery packs that will provide backup power while lowering electric bills. The supplier: electric car maker Tesla Motors, whose CEO Elon Musk is also the chairman of SolarCity.
The Office of Naval Research is demonstrating the Fleet Integrated Synthetic Training/Testing Facility (FIST2FAC) in Florida this week, showing how gaming technology is helping naval forces develop operations strategies in a hassle-free way.
Dow Chemical is looking to separate about 40 manufacturing plants from its business as it continues to concentrate on moving away from cyclical commodity products. The company said it is considering joint ventures, spinoffs or sales. It expects those deals to happen within the next 12 to 24...
Bruker Corp. has announced that it has been granted U.S. FDA clearance under Section 510(k) to market its MALDI Biotyper CA System in the United States for the identification of Gram negative bacterial colonies cultured from human specimens. The clearance marks progress in Bruker’s efforts to develop MALDI-TOF mass spectrometry into the most advanced platform for clinical microbiology identification.
The European Commission has approved the pending acquisition of Life Technologies Corp. by Thermo Fisher Scientific, which has committed to divest its cell culture (sera and media), gene modulation and magnetic beads businesses to expedite the approval. Combined, these businesses had 2012 revenue of approximately $225 million.
Damage to or theft of technical equipment represents a dramatic financial and scientific loss to researchers. Scientists in Germany decided to find out whether the information content and tone of labels attached to the equipment could reduce the incidence of vandalism. They found that a friendly, personal label reduced the interaction of people with the equipment in comparison with neutral or threatening labels.
According to a recent study, fashions in research funding, reward structures in universities and streamlining of scientific agendas undermine traditional academic norms and may result in science bubbles. New research shows how the mechanisms that set off the financial crisis might be replicating in the field of science.
A federal judge on Thursday tossed out a class-action lawsuit brought by authors against Google Inc., clearing the way for the Internet giant to create the world's largest digital library. Google already has scanned more than 20 million books for the project. The Authors Guild, which brought the suit, was seeking $750 for each copyrighted book that was copied.
Google has become less likely to comply with government demands for its users' online communications and other activities as authorities in the U.S. and other countries become more aggressive about mining the Internet for personal data. Legal requests from governments for people’s data have risen 21% from the last half of last year.
Drugmaker Eli Lilly and Co. plans to spend $715 million to bulk up its manufacturing in a key product line, insulin production. The Indianapolis company said it will spend $350 million to expand its insulin cartridge manufacturing in China, another $120 million for a similar improvement in France and $245 million to boost manufacturing capacity in Puerto Rico and Indianapolis.
A federal judge and lawyers for the world's two biggest smartphone makers began picking a jury Tuesday to determine how much Samsung Electronics owes Apple for copying vital iPhone and iPad features. A previous jury had awarded Apple $1.05 billion, but a judge found the jury miscalculated the amount and ordered a new trial to determine how much Samsung should pay.
The widespread use of advanced surveillance technologies by state and local police departments will improve the efficiency of criminal investigations. But a lack of oversight and regulation poses significant privacy concerns, warns Stephen Rushin, a professor of law at the Univ. of Illinois.
A year ago, lawyers for BP and Gulf Coast residents and businesses took turns urging a federal judge to approve their settlement for compensating victims of the company's massive 2010 oil spill. However, the one-time allies will be at odds when an appeals court hears objections to the multibillion-dollar deal.
The Wyss Institute for Biologically Inspired Engineering at Harvard Univ. and AstraZeneca have announced a collaboration that will leverage the Institute's organs-on-chips technologies to better predict safety of drugs in humans. Human organs-on-chips are composed of a clear, flexible polymer about the size of a computer memory stick, and contain hollow microfluidic channels lined by living human cells.
Thomson Reuters announced its 2013 Top 100 Global Innovators this week, a list of the who’s who in innovation based on a series of proprietary patent metrics using its Derwent World Patents Index database. The 2013 honorees comprise many of the likely suspects: AT&T, Apple, Google, Ford, L’Oreal and Microsoft, as well as some that aren’t so likely: Alcatel Lucent, Blackberry and Ericsson.
Any medical device implanted in the body attracts bacteria to its surface, causing infections and thrombosis that lead to many deaths annually. Devices can be coated with antibiotics and blood thinners, but these eventually dissolve, limiting their longevity and effectiveness. Now, Semprus BioSciences is developing a novel biomaterial for implanted medical devices that barricades these troublesome microbes from the device’s surface.
Bridging the gap between research institutes and enterprise is central to advance innovation and competitiveness in Europe, argue European Union (EU) officials and industry leaders. But how to get these separate orbiting planets acquainted with one another was the subject of heated debate at the 5th European Innovation Summit, held in Brussels.
Dow Chemical Co. is selling its global polypropylene licensing and catalysts business to W.R. Grace & Co. for $500 million. The sale includes Dow Chemical's polypropylene catalysts manufacturing plant in Norco, La., and customer contracts, licenses, intellectual property and inventory.
Gilead Sciences said Wednesday it stopped a late-stage clinical trial of a cancer treatment because it was clear the drug was working. Gilead was studying idelalisib as a treatment for chronic lymphocytic leukemia. The company said an early analysis of data from the study showed that patients who were treated with idelalisib had a longer time before the resumption of disease progression or death.
As the government's partial shutdown enters a second day, most companies across the country are doing business as usual. Yet concern is rising that a prolonged shutdown would cause some work at private companies to dry up and consumers to lose faith in the U.S. economy.
The trial resumes Monday for the federal litigation spawned by BP's massive 2010 oil spill in the Gulf of Mexico, with a focus on the company's response to the deadly disaster. At the start of the trial's second phase, U.S. District Judge Carl Barbier is expected to hear two hours of opening statements from lawyers for BP and for Gulf Coast residents and businesses who claim the spill cost them money.
In the 1980s and 1990s, hydroelectric development stagnated as environmental groups lobbied against it and a long regulatory process required years of environmental study. But for the first time in decades, power companies are proposing new projects to take advantage of government financial incentives, policies that promote renewable energy over fossil fuels and efforts to streamline the permit process.
Poor research data can lead to mistakes in equipment selection, over-design of industrial plant components, difficulty simulating and discovering new processes, and poor regulatory decisions. However, traditional peer review is not enough to ensure data quality amid the recent boom in scientific research findings, according to results of a 10-year collaboration between NIST and five technical journals.
The U.S. Environmental Protection Agency (EPA) has launched a web-based tool, called ChemView, to significantly improve access to chemical specific regulatory information developed by EPA and data submitted under the Toxic Substances Control Act. The tool displays key health and safety data in an online format that allows comparison of chemicals by use and by health or environmental effects.
- Page 1